Navigation Links
Embryonic Stem Cell Research Executive Order Places Politics Ahead of Science, Says Michigan Catholic Conference
Date:3/9/2009

LANSING, Mich., March 9 /PRNewswire-USNewswire/ -- Michigan Catholic Conference Vice President for Public Policy Paul A. Long today released the following statement regarding an executive order to be issued by President Obama that permits federal taxpayer funding of embryonic stem cell research:

"President Obama's executive order regrettably places ideology and political posturing ahead of proven scientific therapeutic advancements. There are endless studies and stories of patients who have been treated, even cured of their debilitating condition following stem cell therapies that do not necessitate the destruction of human embryos, yet the president today will sign an executive order that makes every tax-paying American citizen unwittingly complicit in the destruction of human embryos for experimental research.

"In his remarks at the National Prayer Breakfast on February 5, President Obama stated 'There is no God who condones taking the life of an innocent human being. This much we know.' Unfortunately, there is no consistency between this profound statement and today's executive order as destroying human embryos is, in fact, taking the life of an innocent human being."

Michigan Catholic Conference is the official public policy voice of the Catholic Church in this state.


'/>"/>
SOURCE Michigan Catholic Conference
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Leukemia stem cells have more in common with embryonic stem cells than adult stem cells
2. UCI behind worlds first embryonic stem cell study in humans
3. FDA OKs 1st Embryonic Stem Cell Trial
4. Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research
5. Embryonic Stem Cell Research Unethical Waste of Taxpayer Money Says Americans United for Life President
6. New advancements in the use of adult, embryonic stem cells for tissue regeneration
7. Researchers Create Embryonic-Like Stem Cells From Human Testes
8. STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
9. Public funding impacts progress of human embryonic stem cell research
10. Embryonic pathway delivers stem cell traits
11. Embryonic Pathways Induce Stem Cell Traits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... is Men’s Health Month and the focus is on prostate cancer. Second only ... and the third most common cause of cancer related death today; lung cancer remains in ... diagnosed with prostate cancer during his lifetime. Those at highest risk are men ...
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating up and the days ... owners should be aware that the summer months provide more than warmer temperatures that ... keys can be negatively affected from direct exposure to the sun. When it comes ...
(Date:6/23/2017)... Beach, CA (PRWEB) , ... June 23, 2017 , ... ... has earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, ... in the top 1% of all charities reviewed by Charity Navigator and earns ANRF ...
(Date:6/23/2017)... NY (PRWEB) , ... June 23, 2017 , ... ... certified plastic surgeon practicing in Newburgh, New York, has recently begun offering three ... Committed to offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is ...
(Date:6/23/2017)... ... ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach to ... technique that he calls the AuraLyft Facelift. The AuraLyft does more than ... expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach stems ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017  ivWatch LLC, a medical device ... intravenous (IV) therapy, is pleased to announce it was ... Nonsurgical Hospital Supplies and Equipment at the 2017 Medical ... the medtech industry. The award was presented by Medical ... Javits Center in New York ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
(Date:6/8/2017)...   Responding to Heath Ledger,s father,s recent ... singer Chris Cornell in May, the mental health ... free online psychiatric drug side effects search ... psychotropic drug risks. The father of the ... accidental overdose, has called for tighter rules on prescription drugs. ...
Breaking Medicine Technology: